Should You Buy Meridian Bioscience Inc (VIVO) Stock After it Is Up 0.22% in a Week?

Friday, December 02, 2022 03:40 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Meridian Bioscience Inc (VIVO) Stock After it Is Up 0.22% in a Week?

Overall market sentiment has been high on Meridian Bioscience Inc (VIVO) stock lately. VIVO receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Meridian Bioscience Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on VIVO!

See Full VIVO Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With VIVO Stock Today?

Meridian Bioscience Inc (VIVO) stock is flat -0.02% while the S&P 500 has fallen -0.2% as of 3:30 PM on Friday, Dec 2. VIVO is flat $0.00 from the previous closing price of $31.99 on volume of 94,307 shares. Over the past year the S&P 500 has fallen -9.86% while VIVO is up 63.55%. VIVO earned $0.96 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 33.41. To see InvestorsObserver's Sentiment Score for Meridian Bioscience Inc click here.

More About Meridian Bioscience Inc

Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries. Click Here to get the full Stock Report for Meridian Bioscience Inc stock.